vs
Astrana Health, Inc.（ASTH）与STIFEL FINANCIAL CORP（SF）财务数据对比。点击上方公司名可切换其他公司
STIFEL FINANCIAL CORP的季度营收约是Astrana Health, Inc.的1.2倍（$1.1B vs $950.5M），STIFEL FINANCIAL CORP净利率更高（23.5% vs 0.7%，领先22.8%），Astrana Health, Inc.同比增速更快（42.9% vs 23.0%），STIFEL FINANCIAL CORP自由现金流更多（$369.0M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 21.1%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
司迪富金融是美国跨国独立投资银行及金融服务提供商，总部位于密苏里州圣路易斯市中心。其历史可追溯至1890年成立的Altheimer & Rawlings投资公司，1983年正式以Stifel为名成立，1986年11月24日在纽约证券交易所挂牌上市，为全球客户提供多元化金融服务。
ASTH vs SF — 直观对比
营收规模更大
SF
是对方的1.2倍
$950.5M
营收增速更快
ASTH
高出19.9%
23.0%
净利率更高
SF
高出22.8%
0.7%
自由现金流更多
SF
多$374.9M
$-6.0M
两年增速更快
ASTH
近两年复合增速
21.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.1B |
| 净利润 | $6.6M | $264.4M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 27.3% |
| 净利率 | 0.7% | 23.5% |
| 营收同比 | 42.9% | 23.0% |
| 净利润同比 | 184.4% | 8.3% |
| 每股收益（稀释后） | $0.12 | $2.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHSF
| Q4 25 | $950.5M | $1.1B | ||
| Q3 25 | $956.0M | $962.6M | ||
| Q2 25 | $654.8M | $838.9M | ||
| Q1 25 | $620.4M | $842.5M | ||
| Q4 24 | $665.2M | $916.0M | ||
| Q3 24 | $478.7M | $810.9M | ||
| Q2 24 | $486.3M | $798.9M | ||
| Q1 24 | $404.4M | $768.1M |
净利润ASTHSF
| Q4 25 | $6.6M | $264.4M | ||
| Q3 25 | $373.0K | $211.4M | ||
| Q2 25 | $9.4M | $155.1M | ||
| Q1 25 | $6.7M | $53.0M | ||
| Q4 24 | $-7.8M | $244.0M | ||
| Q3 24 | $16.1M | $158.5M | ||
| Q2 24 | $19.2M | $165.3M | ||
| Q1 24 | $14.8M | $163.6M |
营业利润率ASTHSF
| Q4 25 | 1.9% | 27.3% | ||
| Q3 25 | 2.0% | 29.7% | ||
| Q2 25 | 3.1% | 25.5% | ||
| Q1 25 | 3.3% | 7.5% | ||
| Q4 24 | 0.1% | 29.1% | ||
| Q3 24 | 5.9% | 26.7% | ||
| Q2 24 | 6.2% | 28.4% | ||
| Q1 24 | 7.5% | 28.5% |
净利率ASTHSF
| Q4 25 | 0.7% | 23.5% | ||
| Q3 25 | 0.0% | 22.0% | ||
| Q2 25 | 1.4% | 18.5% | ||
| Q1 25 | 1.1% | 6.3% | ||
| Q4 24 | -1.2% | 26.6% | ||
| Q3 24 | 3.4% | 19.5% | ||
| Q2 24 | 3.9% | 20.7% | ||
| Q1 24 | 3.7% | 21.3% |
每股收益（稀释后）ASTHSF
| Q4 25 | $0.12 | $2.30 | ||
| Q3 25 | $0.01 | $1.84 | ||
| Q2 25 | $0.19 | $1.34 | ||
| Q1 25 | $0.14 | $0.39 | ||
| Q4 24 | $-0.14 | $2.10 | ||
| Q3 24 | $0.33 | $1.34 | ||
| Q2 24 | $0.40 | $1.41 | ||
| Q1 24 | $0.31 | $1.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $2.3B |
| 总债务越低越好 | — | $617.4M |
| 股东权益账面价值 | $779.3M | $6.0B |
| 总资产 | $2.2B | $41.3B |
| 负债/权益比越低杠杆越低 | — | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资ASTHSF
| Q4 25 | $429.5M | $2.3B | ||
| Q3 25 | $463.4M | $3.2B | ||
| Q2 25 | $342.1M | $1.9B | ||
| Q1 25 | $260.9M | $2.7B | ||
| Q4 24 | $290.8M | $2.6B | ||
| Q3 24 | $350.3M | $1.9B | ||
| Q2 24 | $327.7M | $2.6B | ||
| Q1 24 | $337.3M | $3.4B |
总债务ASTHSF
| Q4 25 | — | $617.4M | ||
| Q3 25 | — | $617.2M | ||
| Q2 25 | — | $617.0M | ||
| Q1 25 | — | $616.8M | ||
| Q4 24 | — | $616.6M | ||
| Q3 24 | — | $616.4M | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
股东权益ASTHSF
| Q4 25 | $779.3M | $6.0B | ||
| Q3 25 | $775.5M | $5.8B | ||
| Q2 25 | $765.5M | $5.6B | ||
| Q1 25 | $745.4M | $5.5B | ||
| Q4 24 | $712.7M | $5.7B | ||
| Q3 24 | $704.6M | $5.6B | ||
| Q2 24 | $678.9M | $5.4B | ||
| Q1 24 | $653.5M | $5.3B |
总资产ASTHSF
| Q4 25 | $2.2B | $41.3B | ||
| Q3 25 | $2.2B | $41.7B | ||
| Q2 25 | $1.4B | $39.9B | ||
| Q1 25 | $1.3B | $40.4B | ||
| Q4 24 | $1.4B | $39.9B | ||
| Q3 24 | $1.3B | $38.9B | ||
| Q2 24 | $1.3B | $37.8B | ||
| Q1 24 | $1.2B | $38.3B |
负债/权益比ASTHSF
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.11× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $382.4M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $369.0M |
| 自由现金流率自由现金流/营收 | -0.6% | 32.7% |
| 资本支出强度资本支出/营收 | 0.3% | 1.2% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.45× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $1.1B |
8季度趋势，按日历期对齐
经营现金流ASTHSF
| Q4 25 | $-2.9M | $382.4M | ||
| Q3 25 | $10.0M | $338.3M | ||
| Q2 25 | $90.9M | $607.5M | ||
| Q1 25 | $16.6M | $-211.2M | ||
| Q4 24 | $-10.9M | $694.6M | ||
| Q3 24 | $34.0M | $198.3M | ||
| Q2 24 | $23.2M | $207.2M | ||
| Q1 24 | $6.0M | $-609.7M |
自由现金流ASTHSF
| Q4 25 | $-6.0M | $369.0M | ||
| Q3 25 | $7.4M | $321.1M | ||
| Q2 25 | $89.5M | $592.7M | ||
| Q1 25 | $13.6M | $-227.8M | ||
| Q4 24 | $-13.5M | $677.2M | ||
| Q3 24 | $31.7M | $185.6M | ||
| Q2 24 | $20.4M | $173.3M | ||
| Q1 24 | $5.6M | $-619.4M |
自由现金流率ASTHSF
| Q4 25 | -0.6% | 32.7% | ||
| Q3 25 | 0.8% | 33.4% | ||
| Q2 25 | 13.7% | 70.6% | ||
| Q1 25 | 2.2% | -27.0% | ||
| Q4 24 | -2.0% | 73.9% | ||
| Q3 24 | 6.6% | 22.9% | ||
| Q2 24 | 4.2% | 21.7% | ||
| Q1 24 | 1.4% | -80.6% |
资本支出强度ASTHSF
| Q4 25 | 0.3% | 1.2% | ||
| Q3 25 | 0.3% | 1.8% | ||
| Q2 25 | 0.2% | 1.8% | ||
| Q1 25 | 0.5% | 2.0% | ||
| Q4 24 | 0.4% | 1.9% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 0.6% | 4.2% | ||
| Q1 24 | 0.1% | 1.3% |
现金转化率ASTHSF
| Q4 25 | -0.44× | 1.45× | ||
| Q3 25 | 26.69× | 1.60× | ||
| Q2 25 | 9.65× | 3.92× | ||
| Q1 25 | 2.48× | -3.99× | ||
| Q4 24 | — | 2.85× | ||
| Q3 24 | 2.11× | 1.25× | ||
| Q2 24 | 1.21× | 1.25× | ||
| Q1 24 | 0.40× | -3.73× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SF
暂无分部数据
